Swiss-Life auch in Wirecard-Sumpflandschaft verwickelt...
Gierige Swiss Life bringt Land in Wirecard-Not
Scheint sich erst mal alles Richtung in zyklische Industriewerte zu wenden
Neues von der CH-Virenfront...Schlieren ist so eine Art Silicon-Valley für Biotechs in der CH. Besonders Roche/Novartis greifen dort oft zu um sich auszubreiten.
BAG sichert sich Kaufoption für potenzielles COVID-Mittel von Molecular Partners
ISSUER: CUREVAC N.V.
TICKER: CVAC
SECTOR: BIOTECHNOLOGY
COUNTRY: GERMANY
OFFER TYPE: INITIAL PUBLIC OFFERING (100% PRIMARY)
LISTING VENUE: NASDAQ
OFFER SIZE: $200M USD – AT MIDPOINT OF RANGE (EXCLUDING 15% GREENSHOE)
SHARES: 13,333,333
OFFER PRICE: $14.00 - $16.00 PER SHARE
IMPLIED MARKET CAP: $2,679M USD – AT MIDPOINT OF RANGE
SHARE TYPE: COMMON SHARES
OVER-ALLOTMENT OPTION: 15%
USE OF PROCEEDS:
TO ADVANCE LEAD ONCOLOGY PROGRAM, CV8102, THROUGH PHASE 2, ADVANCE LEAD VACCINE PROGRAM, CV7202, THROUGH PHASE 2, FUND DEVELOPMENT OF SARS-COV-2 PROGRAM THROUGH PHASE 2, ADVANCE OTHER PROGRAMS, EXPAND MANUFACTURING CAPABILITIES, WORKING CAPITAL AND GENERAL CORPORATE PURPOSES
BOOKRUNNER(S):
BOFA SECURITES, JEFFERIES, CREDIT SUISSE, BERENBERG, KEMPEN & CO
LAUNCH DATE:
AUGUST 10, 2020
EXPECTED PRICING DATE:
AUGUST 13, 2020 (POST CLOSE)
EXPECTED FIRST TRADE DATE:
AUGUST 14, 2020
Plug Power Inc. Announces Pricing of Public Offering of Common Stock
(Veröffentlichung stammt von gestern Abend)
"... today announced the pricing of the previously announced offering of 30,675,000 shares of its common stock at a price to the public of $10.25 per share. Plug Power has granted the underwriters a 30-day option to purchase up to an additional 4,601,250 shares at the public offering price, less the underwriting discount....
TEAM schnuppert erneut auf Langzeit Support-Linie
Scheint sich erst mal alles Richtung in zyklische Industriewerte zu wenden
Kurzes Gastspiel. Russell 2000 mit Mini-Top und die Solar-Werte laufen vorne weg
ORLY mit HMA Bull, Gap-Close und vorzüglichem CRV
CDNS mit HMA Bull an unterkante Trendkanal